Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Phospho-mTOR is not upregulated in metastatic SDHB paragangliomas.

Ghayee HK, Giubellino A, Click A, Kapur P, Christie A, Xie XJ, Martucci V, Shay JW, Souza RF, Pacak K.

Eur J Clin Invest. 2013 Sep;43(9):970-7. doi: 10.1111/eci.12127. Epub 2013 Jul 26.

PMID:
23889685
[PubMed - indexed for MEDLINE]
2.

Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas: identification of a novel nonsense mutation (Q168X) in the SDHB gene.

Oishi Y, Nagai S, Yoshida M, Fujisawa S, Sazawa A, Shinohara N, Nonomura K, Matsuno K, Shimizu C.

Endocr J. 2010;57(8):745-50. Epub 2010 May 25.

PMID:
20505258
[PubMed - indexed for MEDLINE]
Free Article
3.

SDHB loss predicts malignancy in pheochromocytomas/sympathethic paragangliomas, but not through hypoxia signalling.

Blank A, Schmitt AM, Korpershoek E, van Nederveen F, Rudolph T, Weber N, Strebel RT, de Krijger R, Komminoth P, Perren A.

Endocr Relat Cancer. 2010 Oct 5;17(4):919-28. doi: 10.1677/ERC-09-0316. Print 2010 Dec.

PMID:
20702724
[PubMed - indexed for MEDLINE]
Free Article
4.

Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.

Pollard PJ, El-Bahrawy M, Poulsom R, Elia G, Killick P, Kelly G, Hunt T, Jeffery R, Seedhar P, Barwell J, Latif F, Gleeson MJ, Hodgson SV, Stamp GW, Tomlinson IP, Maher ER.

J Clin Endocrinol Metab. 2006 Nov;91(11):4593-8. Epub 2006 Sep 5.

PMID:
16954163
[PubMed - indexed for MEDLINE]
5.

Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB/D-related paraganglioma: initial experimental and ex vivo findings.

Lendvai N, Pawlosky R, Bullova P, Eisenhofer G, Patocs A, Veech RL, Pacak K.

Endocrinology. 2014 Jan;155(1):27-32. doi: 10.1210/en.2013-1549. Epub 2013 Dec 20.

PMID:
24189137
[PubMed - indexed for MEDLINE]
6.

Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas.

López-Jiménez E, Gómez-López G, Leandro-García LJ, Muñoz I, Schiavi F, Montero-Conde C, de Cubas AA, Ramires R, Landa I, Leskelä S, Maliszewska A, Inglada-Pérez L, de la Vega L, Rodríguez-Antona C, Letón R, Bernal C, de Campos JM, Diez-Tascón C, Fraga MF, Boullosa C, Pisano DG, Opocher G, Robledo M, Cascón A.

Mol Endocrinol. 2010 Dec;24(12):2382-91. doi: 10.1210/me.2010-0256. Epub 2010 Oct 27.

PMID:
20980436
[PubMed - indexed for MEDLINE]
7.

Warburg effect's manifestation in aggressive pheochromocytomas and paragangliomas: insights from a mouse cell model applied to human tumor tissue.

Fliedner SM, Kaludercic N, Jiang XS, Hansikova H, Hajkova Z, Sladkova J, Limpuangthip A, Backlund PS, Wesley R, Martiniova L, Jochmanova I, Lendvai NK, Breza J, Yergey AL, Paolocci N, Tischler AS, Zeman J, Porter FD, Lehnert H, Pacak K.

PLoS One. 2012;7(7):e40949. doi: 10.1371/journal.pone.0040949. Epub 2012 Jul 31.

PMID:
22859959
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas.

Shankavaram U, Fliedner SM, Elkahloun AG, Barb JJ, Munson PJ, Huynh TT, Matro JC, Turkova H, Linehan WM, Timmers HJ, Tischler AS, Powers JF, de Krijger R, Baysal BE, Takacova M, Pastorekova S, Gius D, Lehnert H, Camphausen K, Pacak K.

Neoplasia. 2013 Apr;15(4):435-47.

PMID:
23555188
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways.

de Cubas AA, Leandro-García LJ, Schiavi F, Mancikova V, Comino-Méndez I, Inglada-Pérez L, Perez-Martinez M, Ibarz N, Ximénez-Embún P, López-Jiménez E, Maliszewska A, Letón R, Gómez Graña A, Bernal C, Alvarez-Escolá C, Rodríguez-Antona C, Opocher G, Muñoz J, Megias D, Cascón A, Robledo M.

Endocr Relat Cancer. 2013 Jun 24;20(4):477-93. doi: 10.1530/ERC-12-0183. Print 2013 Aug.

PMID:
23660872
[PubMed - indexed for MEDLINE]
10.

Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene.

Timmers HJ, Pacak K, Huynh TT, Abu-Asab M, Tsokos M, Merino MJ, Baysal BE, Adams KT, Eisenhofer G.

J Clin Endocrinol Metab. 2008 Dec;93(12):4826-32. doi: 10.1210/jc.2008-1093. Epub 2008 Oct 7.

PMID:
18840642
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Clinical aspects of SDHx-related pheochromocytoma and paraganglioma.

Timmers HJ, Gimenez-Roqueplo AP, Mannelli M, Pacak K.

Endocr Relat Cancer. 2009 Jun;16(2):391-400. doi: 10.1677/ERC-08-0284. Epub 2009 Feb 3. Review.

PMID:
19190077
[PubMed - indexed for MEDLINE]
Free Article
12.

Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.

Korpershoek E, Petri BJ, van Nederveen FH, Dinjens WN, Verhofstad AA, de Herder WW, Schmid S, Perren A, Komminoth P, de Krijger RR.

Endocr Relat Cancer. 2007 Jun;14(2):453-62.

PMID:
17639058
[PubMed - indexed for MEDLINE]
Free Article
13.

Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations.

Loriot C, Burnichon N, Gadessaud N, Vescovo L, Amar L, Libé R, Bertherat J, Plouin PF, Jeunemaitre X, Gimenez-Roqueplo AP, Favier J.

J Clin Endocrinol Metab. 2012 Jun;97(6):E954-62. doi: 10.1210/jc.2011-3437. Epub 2012 Apr 4.

PMID:
22492777
[PubMed - indexed for MEDLINE]
14.

Hereditary Paraganglioma-Pheochromocytoma Syndromes.

Kirmani S, Young WF.

In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2014.
2008 May 21 [updated 2012 Aug 30].

PMID:
20301715
[PubMed]
Books & Documents
15.

Paragangliomas: update on differential diagnostic considerations, composite tumors, and recent genetic developments.

Papathomas TG, de Krijger RR, Tischler AS.

Semin Diagn Pathol. 2013 Aug;30(3):207-23. doi: 10.1053/j.semdp.2013.06.006. Review.

PMID:
24144290
[PubMed - indexed for MEDLINE]
16.

Usefulness of negative and weak-diffuse pattern of SDHB immunostaining in assessment of SDH mutations in paragangliomas and pheochromocytomas.

Castelblanco E, Santacana M, Valls J, de Cubas A, Cascón A, Robledo M, Matias-Guiu X.

Endocr Pathol. 2013 Dec;24(4):199-205. doi: 10.1007/s12022-013-9269-4.

PMID:
24096807
[PubMed - indexed for MEDLINE]
17.

High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations.

Lima J, Feijão T, Ferreira da Silva A, Pereira-Castro I, Fernandez-Ballester G, Máximo V, Herrero A, Serrano L, Sobrinho-Simões M, Garcia-Rostan G.

J Clin Endocrinol Metab. 2007 Dec;92(12):4853-64. Epub 2007 Sep 11.

PMID:
17848412
[PubMed - indexed for MEDLINE]
18.

Mediastinal paragangliomas: association with mutations in the succinate dehydrogenase genes and aggressive behavior.

Ghayee HK, Havekes B, Corssmit EP, Eisenhofer G, Hammes SR, Ahmad Z, Tessnow A, Lazúrová I, Adams KT, Fojo AT, Pacak K, Auchus RJ.

Endocr Relat Cancer. 2009 Mar;16(1):291-9. doi: 10.1677/ERC-08-0214. Epub 2008 Dec 15.

PMID:
19075037
[PubMed - indexed for MEDLINE]
Free Article
19.

Comparison of clinical and imaging features in succinate dehydrogenase-positive versus sporadic paragangliomas.

Venkatesan AM, Trivedi H, Adams KT, Kebebew E, Pacak K, Hughes MS.

Surgery. 2011 Dec;150(6):1186-93. doi: 10.1016/j.surg.2011.09.026.

PMID:
22136839
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Hereditary paragangliomas.

Raygada M, Pasini B, Stratakis CA.

Adv Otorhinolaryngol. 2011;70:99-106. doi: 10.1159/000322484. Epub 2011 Feb 24. Review.

PMID:
21358191
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk